Back to search

Article

Gene-drug interactions identify genomic loci that enhance statin effectiveness in lowering LDL cholesterol

2026-02-06

Abstract excerpt

Hyperlipidemia, and high low-density lipoprotein cholesterol (LDL-c) in particular, is a risk factor for cardiovascular disease, including atherosclerosis, myocardial infarction, and stroke. Nearly 200 million people worldwide take HMG-CoA reductase inhibitors, commonly known as statins, to lower their LDL-c. If statins interfere with the genetic pathways that endogenously increase the risk for hyperlipidemia, gen...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
c9be2cb5-3d36-59fb-a4ff-0e2b8c91a76d
DOI
10.64898/2026.02.04.703692
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Gene-drug interactions identify genomic loci that enhance statin effectiveness in lowering LDL cholesterolDOI 10.64898/2026.02.04.703692
Select a neighboring publication to make it the new centre.